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Abstract. Native top-down mass spectrometry is
a fast, robust biophysical technique that can pro-
vide molecular-scale information on the interac-
tion between proteins or peptides and ligands,
including metal cations. Here we have analyzed
complexes of the full-length amyloid β (1-42)
monomer with a range of (patho)physiologically
relevant metal cations using native Fourier trans-
form ion cyclotron resonance mass spectrometry
a n d t h r e e d i f f e r e n t f r a gm e n t a t i o n
methods—collision-induced dissociation, electron capture dissociation, and infrared multiphoton
dissociation—all yielding consistent results. Amyloid β is of particular interest as its oligomerization and aggre-
gation are major events in the etiology of Alzheimer’s disease, and it is known that interactions between the
peptide and bioavailable metal cations have the potential to significantly damage neurons. Those metals which
exhibited the strongest binding to the peptide (Cu2+, Co2+, Ni2+) all shared a very similar binding region containing
two of the histidine residues near the N-terminus (His6, His13). Notably, Fe3+ bound to the peptide only when
stabilized toward hydrolysis, aggregation, and precipitation by a chelating ligand, binding in the region between
Ser8 and Gly25. We also identified two additional binding regions near the flexible, hydrophobic C-terminus,
where other metals (Mg2+, Ca2+, Mn2+, Na+, and K+) bound more weakly—one centered on Leu34, and one on
Gly38. Unexpectedly, collisional activation of the complex formed between the peptide and [CoIII(NH3)6]
3+
induced gas-phase reduction of the metal to CoII, allowing the peptide to fragment via radical-based dissociation
pathways. This work demonstrates how native mass spectrometry can provide new insights into the interactions
between amyloid β and metal cations.
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Introduction
Gaining insight into protein-protein, protein-ligand, andprotein-metal interactions at the molecular level is critical
for understanding the biological function of proteins. For ex-
ample, it has been estimated that metalloproteins alone make
upmore than a third of all proteins [1, 2]. Widely used methods
for elucidating such interactions include nuclear magnetic
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resonance (NMR) spectroscopy and X-ray crystallography.
However, these biophysical techniques typically are limited
in terms of sample throughput, and NMR in particular often
samples ensemble averages if multiple interaction regions/
stoichiometries coexist, depending on the timescales of
exchange.
Native mass spectrometry (MS) is a fast, robust method that
allows study of intact noncovalent protein-protein and protein-
ligand/metal complexes in the gas phase [3–5]. While the lack
of a hydrophobic effect in the absence of water originally led to
speculation that protein ions in vacuo would turn “inside out”
[6], it is currently believed that instead they retain many aspects
of their native structure, including overall shape, complex
stoichiometry, and binding of ligands, even those that are
hydrophobically bound [7–10]. Combined with top-down frag-
mentation, native MS provides a powerful tool for obtaining
information about higher-order structure, including subunit
connectivity and ligand binding site(s) [11–13]. Often, binding
sites can be determined with single-residue specificity, al-
though this requires extensive backbone cleavage in the region
of interest, which is often not achieved in practice. This tech-
nique is also ideally and uniquely suited for systems where
multiple states coexist, as a specific precursor is almost always
selected based on its mass-to-charge (m/z) ratio.
In this work, we have used high-resolution Fourier trans-
form ion cyclotron resonance (FTICR) mass spectrometry to
gain insight into the sequence regions involved in peptide-
metal interactions. We have used electron capture dissociation
(ECD), infrared multiphoton dissociation (IRMPD), and
collision-induced dissociation (CID), to determine the
peptide-metal interaction sites. In this type of “native top-
down” study [14], it is always a concern whether the binding
site remains the same during the dissociation process. It has
been shown that the increase in internal energy during CID can
lead not only to loss but also to migration of a noncovalently
bound ligand [15]. ECD has been used successfully to study
binding sites of anticancer complexes to biomolecules [16–21];
however, the charge reduction inherent to ECD in some cases is
capable of disrupting ion-dipole interactions and this mecha-
nism can also induce ligand migration [22]. While, therefore,
there are indications that results from each of our three disso-
ciation methods in isolation should not be fully accepted a
priori, consistent results from all three methods allow confident
identification of the true gas-phase binding region, given the
fundamentally different fragmentation mechanisms involved.
An important objective of this study was to investigate to what
extent results from the three methods differ. This is because
consistency between all three across the relatively broad range
of metals tested here would be a strong indication that each
method in isolation can be used to identify metal cation binding
regions, and that it would generally suffice in such a study to
use the method most conveniently available and/or that would
lead to the most efficient dissociation.
Amyloid β (1-42) was used as a model peptide in this work.
Misfolding and accumulation of this peptide, particularly the
40- and 42-residue isoforms, are widely believed to play a
major role in the pathogenesis of Alzheimer’s disease, the most
prevalent neurodegenerative disease worldwide. It is less wide-
ly recognized that interactions between certain trace metals and
the peptide play an important role in disease etiology [23–27].
Such interactions have been studied in both in vitro and ex vivo
samples, using a range of techniques, including fluorescence
assays [27–29], NMR [28–30], Raman [26], and synchrotron
X-ray spectromicroscopy [31–33]. In the current work, the
metal ions Na+, K+, Mg2+, Ca2+, Mn2+, Co2+, [Co(NH3)6]
3+,
Ni2+, Cu2+, and Fe3+ were reacted with buffered aqueous
solutions of the full-length peptide. These metal cations were
mainly chosen because they easily and reproducibly lead to the
formation and detection of amyloid-metal complexes under the
in vitro conditions used here, but with the exception of
[Co(NH3)6]
3+, they are also all physiologically or
pathophysiologically relevant [24, 31, 33–41]. Although there
is widespread interest in the possible involvement of Zn2+ and
Al3+ in neurodegeneration on account of their known or
suspected dysregulation functions in Alzheimer’s disease, we
were unable to obtain consistent MS data for binding of these
metal cations to amyloid β (1-42), and so no results are reported
here. We believe this is due to their complicated hydrolytic
chemistry at physiological pH (formation of hydroxide-bridged
oligomers, etc.), as we will illustrate for Fe3+. Although rarely
mentioned in the context of AD, Co is included and potentially
of interest following a reported increase in brain Co in AD
patients versus healthy controls [42]. Interest in Ca has primar-
ily focussed on signalling, and in the context of amyloid
accumulation, we highlight our recent observation of diverse
calcium biomineral phases within amyloid plaques isolated
from humans with AD [33].
Experimental
MS experiments were performed on a 12 T solariX quadrupole/
FTICR instrument (Bruker Daltonik GmbH, Bremen, Germa-
ny) equipped with an infinity cell and advanced dissociation
methods, including electron capture dissociation and infrared
multiphoton dissociation. Ions were introduced using nano-ESI
in positive ion mode and externally accumulated in a hexapole
collision cell before being transferred to the ICR cell. The ESI
source used 1.2-mm thin-walled glass capillaries (World Pre-
cision Instruments, Hitching, UK) that were pulled in-house to
obtain tips of ca. 1-μm orifice diameter with a P97 Flaming/
Brown type micropipette puller (Sutter Instrument Co., Nova-
to, CA, USA). For CID and ECD experiments, precursor ions
were selected in the quadrupole of the solariX instrument. For
IRMPD, in-cell isolation was performed using the correlated
harmonic excitation fields (CHEF) method [43], with a notch
width of 3 to 5 m/z, and excitation energy of 55%. ECD was
performed by generating electrons from a heated hollow cath-
ode, using a current of 1.5 A. IRMPD was performed using a
Synrad 48-2 25 W CO2 laser with a 10.6-μm wavelength
operated at 50% power. Data analysis was performed using
Bruker Compass DataAnalysis 4.1, and peaks were assigned
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manually. Detailed peak assignment tables can be found in
Supporting Information S7. To preserve native peptide-metal
interactions, samples were prepared in Milli-Q H2O containing
25 mM ammonium acetate (pH 7.4). Amyloid β (1-42) (mon-
oisotopic mass 4511.27 Da) was purchased from Bachem
(Bubendorf, Switzerland). The concentration of the peptide
was kept constant at 12.5 μM. NaCl, KCl, MgSO4, CaCl2,
MnCl2, [Co(NH3)6]Cl3, CoCl2, CuSO4, NiCl2, FeCl3, and
nitrilotriacetic acid were purchased from Sigma (Dorset, UK).
Transmission electron microscopy (TEM) images were ac-
quired using a JEOL 2010 microscope operated at 200 kV,
and negative staining was performed using uranyl acetate.
Results and Discussion
The non-traditional buffer required for native MS
of amyloid-metal complexes did not prevent normal
fibril formation
As a first step, we briefly investigated the use of different buffers
to study amyloid-metal interactions by mass spectrometry. Most
literature reports do not employ MS and have used conventional
molecular biology buffers, such as phosphate-buffered saline
(PBS), and performing MS using these buffers would have the
benefit of eliminating one potential source of discrepancy when
comparing our results to the literature. Unfortunately, these
conventional buffers contain significant levels of non-volatile
cations, such as Na+, which are generally considered incompat-
ible with (nano-)electrospray mass spectrometry. Recently, Wil-
liams et al. have demonstrated an approach, based on the use of
sub-μM ESI emitters, that seems to allow observation of native-
like charge state distributions from a range of non-volatile
buffers [44–47]. There have been concerns that use of these
emitters leads to significant interaction between the protein and
the negatively charged glass surface [46] as well as a decrease in
pH at the emitter tip [48], possibly causing denaturation [48, 49].
Furthermore, as a stable spray over the time scale of the
experiment—typically ca. 45 min, up to several hours in some
cases—was needed for tandem MS, we wanted to avoid the
previously acknowledged clogging issues associated with these
ultrafine emitters [45], especially as these issues are likely to be
exacerbated when spraying an aggregation-prone peptide such
as amyloid β. As such, we opted to use more conventional nano-
ESI emitters (described in the “Experimental” section) when
comparing different buffers.
To avoid excessive Na+ concentrations, a buffer was pre-
pared based on ammonium acetate and ammonium phosphate,
and the pH was adjusted to 7.4 by dropwise addition of 35%
aqueous NH3. Similarly, an analog for Krebs-Henseleit (KH)
buffer, which we have used in previous—synchrotron-
based—studies of amyloid/metal interactions [50, 51] was
made based on ammonium acetate and piperazine-N,N′-bis(2-
ethanesulfonic acid) (PIPES). Performance of these buffers was
compared to pure water and aqueous ammonium acetate.
While some peptide signal was detected using this phosphate-
containing buffer, signal intensity was low and significant
adduct formation of the peptide with H3PO4 clusters was
observed (data not shown). In the KH buffer analog, no peptide
signal was detected and it was found that PIPES even at a
concentration as low as 1 mM completely suppressed peptide
ionization. The use of pure H2O led to very good signal
intensity; however, significant peptide binding to trace
amounts of Na+ was observed, whereas this was mostly
abolished by adding ammonium acetate. As a result, it was
decided to carry out the rest of these experiments using 25 mM
aqueous ammonium acetate. It could be questioned as to what
extent results obtained in (non-physiological) ammonium ace-
tate buffer are relevant for understanding the peptide’s normal
behavior. To verify that amyloid β (1-42) did not lose its
capability to aggregate under these conditions, peptide solu-
tions were prepared in aqueous ammonium acetate, pure H2O,
and KH buffer, and incubated for 375 h (approximately 15
days) at 37 °C. Subsequent TEM imaging of these samples in
all cases revealed the typical fibril networks expected for this
peptide (see Supporting Information S1).
Formation of amyloid-metal complexes was
straightforward in most cases, but Fe3+ required
stabilization toward hydrolysis and aggregation
by a chelating agent at physiological pH
For mass spectrometry, we initially added 12.5 μM of metal
salt to the peptide solution, to provide a 1:1 molar ratio, and
measured the degree of adduct formation with native MS. This
way, abundant adduct formation with Cu2+, Ni2+, and Co2+was
observed (see Supporting Information S2). The other metals
showed no or only limited binding under these conditions, so
their concentration was increased to 125 μM (i.e., a
metal:peptide molar ratio of 10:1), leading to significant adduct
formation in most cases (Supporting Information S2). For Na+
and K+, adduct formation was still quite limited even under
these conditions, likely a result of these alkali metals competing
for binding sites with the far more abundant (25 mM) singly
charged NH4
+ ion from ammonium acetate. The fact that
adducts with the NH4
+ ions were not observed is easily ex-
plained by the facile loss of NH3 in the gas phase [52]. As
addition of NaCl or KCl did not significantly affect the solution
pH, it was decided to test binding of these cations in pure H2O,
without addition of ammonium acetate. Under these condi-
tions, sufficient binding for tandem MS was observed at a
metal cation concentration of 12.5 μM (Supporting
Information S2). Based on their ability to bind most of the
available peptide in solution when added in a 1:1 ratio, even in
the presence of ammonium acetate, we conclude that, of the
metals tested here, Cu2+, Ni2+, and Co2+ bind most strongly to
amyloid β (1-42).
Increasing the FeCl3 concentration or incubation time did
not lead to any observed binding of Fe3+ to the peptide, in
agreement with previous work byMessori et al. [53]. The most
likely explanation for this is the hydrolysis and acidity of aqua
adducts, and aggregation and precipitation of bridged
hydroxide/oxo species leading to poor solubility of this ion at
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physiological pH. To overcome this issue, we solubilized the
Fe3+ using a chelating agent, an approach which has been
successfully applied previously [54–56]. Briefly,
nitrilotriacetic acid (H3NTA) was added to an aqueous
10 mM solution of FeCl3 in order to give a 1:1 mol ratio. The
pH was subsequently adjusted to 7.4 by dropwise addition of
1 M aqueous NH3. Under these conditions, nitrilotriacetate
(NTA3-) can act as a tetradentate ligand, with H2O and OH
−
coordinating to the Fe3+ center, bringing the total coordination
number to six [57]. This resulted in a clear solution with no
visible precipitate, which was added to the 12.5 μM amyloid β
solution. As was done for the other metals, we initially chose
our dilution to obtain a 1:1 ratio of amyloid to the [Fe-NTA]
complex. As this resulted in only very limited observation of
the ternary [amyloid-Fe-NTA] complex, we increased the iron-
NTA concentration to 500 μM, corresponding to a 40:1
iron:peptide ratio. This resulted in the observation of a suffi-
ciently intense [Aβ + Fe3+ + NTA3− + 4H]4+ signal to allow
interrogation by tandem MS (see Supporting Information S3).
No mass increase due to H2O or OH
− was observed in this
complex; therefore, it seems likely that these were replaced by
side chains with a free electron pair. Activation of the ternary
complex using either collisions with argon atoms or irradiation
by infrared laser resulted in the loss of neutral H3NTA and the
observation of [Aβ + Fe + H]4+ (Figure 1). The fact that the
chelating agent is lost as a protonated species under these
conditions is perhaps surprising; however, loss of a 3− anion
from a 7+ cation is likely to be energetically unfavorable. It has
been shown previously that multiply charged protein cations
can act as surprisingly strong proton donors in the gas phase
due to electrostatic repulsion between protons [58]. Interest-
ingly, further activation of this ion resulted in backbone cleav-
age rather than the observation of any iron-free amyloid (vide
infra), indicating that the gas-phase interaction between Fe3+
and the amyloid was strong, consistent with our hypothesis that
solubility was the limiting factor in the initial experiments. It
has been suggested in the past that ferritin—a water-soluble
protein complex and the primary Fe3+ reservoir in the
brain—might be the origin of the mixed oxidation state iron
phases that have been identified in plaque core material ex-
tracted from Alzheimer’s disease brain tissue [33, 59]. There-
fore, improved understanding of the interaction between amy-
loid β (1-42) and Fe3+ could provide insight into an important
event in the etiology of Alzheimer’s disease.
As shown in Supporting Information S3, despite our at-
tempts to eliminate sodium contamination from these experi-
ments, a few Na+-related “satellite” peaks were observed,
likely due to the presence of trace amounts of Na+ in the
H3NTA. Using the quadrupole mass filter of the solariX instru-
ment, isolation of the [Aβ + Fe3+ + NTA3− + 4H]4+ ion with a
sufficiently narrow window (approximately 4 m/z) to eliminate
these satellite signals resulted in a significant decrease in the
precursor ion signal, complicating tandemMS experiments. As
a result, in-cell isolation using CHEF was performed, resulting
in near-complete elimination of Na+-related signals with min-
imal signal loss (see Supporting Information S3). As collisional
activation within the ICR cell is not trivial, subsequent ion
activation was performed using IRMPD. ECD of the [Aβ +
Fe + H]4+ complex only resulted in non-dissociative charge
reduction, which we attribute to the fact that three of the four
protons in the peptide ion were replaced with the metal cation
in this case. The IRMPD results will be discussed in detail later.
First, we turn our focus toward an in-depth analysis of tandem
MS results for the other amyloid-metal complexes, which were
successfully interrogated with all three fragmentation methods.
CID, ECD, and IRMPD all resulted in consistent
determination of binding regions for eight (patho)
physiologically relevant metals, indicating that
gas-phase ligand migration did not occur
to a significant extent in these experiments
For the complexes of amyloid β with Na+, K+, Mg2+, Ca2+,
Mn2+, Co2+, Ni2+, and Cu2+, the 4+ charge state was isolated
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Figure 1. (a) Formation of [Aβ + Fe3+ + H]4+ after IR activation
of the ternary complex between amyloid β and [Fe-NTA]. Inset
shows the observed and calculated isotope distribution of the
product ion, confirming the 3+ oxidation state of Fe. Longer
exposure to the IR laser induced backbone fragmentation, as
shown in (b). The observed b/y fragment ions both with and
without bound Fe3+ are summarized below the fragment spec-
trum, and the apparent binding region is indicated with a yellow
highlight. Fragment charge states are indicated using a color
code
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and subjected to fragmentation using CID (30 V collision
energy), IRMPD, and ECD. For ECD, limited concomitant
infrared activation [60–62] improved fragmentation efficiency
without inducing the formation of the b/y ions that are charac-
teristic for IRMPD fragmentation, and this supplemental acti-
vation was used in all cases. Regardless of the choice of
fragmentation technique, numerous fragments carrying the
metal were observed, providing information on the gas-phase
binding region. Briefly, observation of a metal-bound N- (or C-
)terminal fragment consisting of n residues provides strong
evidence that at least one residue of the first (or last) n coordi-
nates the metal ion. Conversely, observation of a metal-free
fragment consisting ofm residues can be taken as evidence that
the first (or last) m residues do not interact strongly with the
metal, although this does not necessarily hold if loss or migra-
tion of the metal is energetically more favorable than backbone
cleavage and this therefore provides weaker evidence. From
the above, it follows that, if multiple residues are involved in
coordinating the metal cation, this can result in a “gap” where
no fragmentation is observed. As metal cations are generally
coordinated by several amino acid residues simultaneously,
this method allows the determination of a binding region rather
than detailed characterization of the metal binding site in the
metal-amyloid complexes studied here.
For any given complex, the identified binding region was
relatively consistent, regardless of the dissociation method
used. While ECD selectively cleaves the N-Cα bond in the
peptide backbone, and has therefore long been established [9,
13, 63–68] as a method for identifying noncovalent ligand
binding sites, this result was somewhat unexpected for CID
and IRMPD, as these are both considered “slow-heating”
methods [69]. Indeed, for most noncovalent ligands, the grad-
ual increase of internal energy, and distribution of this energy
across the ion’s internal degrees of freedom, often leads to loss
of these ligands prior to backbone fragmentation [64]. Howev-
er, due to the ca. 80-fold lower dielectric permittivity of vacu-
um compared with water, electrostatic interactions were signif-
icantly strengthened, explaining why metal binding survived
the CID process, while cleavage of backbone amide bonds was
observed [70–73].
The identified metal binding regions for all metals are
summarized in Table 1. A detailed overview of the identified
fragments in tandem MS of complexes with Cu2+, Na+, and
Ca2+ is shown in Figures 2d, 3d, and 4d, respectively. A similar
overview for Co2+, Ni2+, K+, Mn2+, and Mg2+ can be found in
Supporting Information S4. Co2+ and Ni2+ bound in a very
similar region to Cu2+; K+ bound in a similar way to Na+; and
Mn2+ and Mg2+ bound in the same region as Ca2+. Interesting-
ly, the three metal ions that bound strongly at a low concentra-
tion (Ni2+, Cu2+, and Co2+) all did so in the N-terminal region.
In IRMPD and CID of the Cu2+ adduct (Figure 2), all metal-
bound fragments contained the [Asp1–His13] region. In these
spectra, the isotope distribution of a number of copper-bound
fragment peaks was shifted upward by one hydrogen mass (as
indicated in Figure 2d), most likely due to gas-phase reduction
of Cu2+ to Cu+. Also, a c7
+ fragment and a small number of a
fragments were observed. This behavior is consistent with
radical-directed dissociation, which will be discussed in detail
when discussing results for top-down CID of the amyloid-
[Co(NH3)6] complex (vide infra). Details of the in vitro and
ex vivo interaction between amyloid β and copper are consid-
ered in a forthcoming paper. The IR-ECD spectrum of native
[Aβ + 2H + Cu]4+ revealed that the [Arg5–Gln15]
region—which includes His6, His13, and His14—contained
the Cu2+ binding site (Figure 2b, d). Combined, these data
suggest that the metal ion was coordinated by ligands in the
N-terminal region, likely including His6 and His13. Important-
ly, this finding matches literature results obtained using other
(solution-phase) methods [30, 34]. This match, along with the
remarkable consistency between CID, IRMPD, and ECD re-
sults, provides compelling evidence that the metal binding site
remained more or less unchanged during ionization and trans-
fer into the gas phase, and hence that the method used here
accurately probed these sites on amyloid β.
The hypothesis that several residues were involved in coor-
dinating these metals is supported by the fragmentation of the
Ni2+-bound peptide (Supporting Information S4). In both CID
and IRMPD, a metal-bound b6 fragment was observed, dem-
onstrating an interaction between the metal and (at least one of)
the first six N-terminal residues of the peptide. Metal-bound b7
and b12 fragments were exclusively found in the CID spectrum,
and signal intensity increased significantly for fragments larger
than b12, which contain both His6 and His13. At the same time,
the observation of metal-bound z30, z32, z33, and z34 in ECD
provided evidence that binding of Ni2+ involves at least one of
the residues in the [His13–Ala42] region. Therefore, our data
indicated that Ni2+ is coordinated by multiple ligands, includ-
ing His6 and His13. This is consistent with findings reported
Table 1. Overview of Identified Binding Regions for the Metal Cations Inves-
tigated in This Study. Dotted Lines Are Used to Divide the Metals into Groups
with Similar Binding Regions
Caon Binding region
Cu2+ [Arg5 – His13]
Ni2+ [His6 – His14]
Co2+ [Glu3 – His13]
Fe3+ [Ser8 – Gly25]
Na+ [Val36 – Gly37]
K+ [Val39 – Val40]
Ca2+ [Gly33 – Gly37]
Mg2+ [Ile32 – Gly37]
Mn2+ [Gly33 – Met35]
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by Sóvágó and colleagues, who used UV-Vis and circular
dichroism spectroscopy to study the complex formed between
Ni2+ and amyloid β (1-16) in solution [34]. Similarly, for the
Co2+ adduct, the observation of metal-bound b13 (CID) and z40
(IR-ECD) fragments restricted the possible binding site to
[Glu3–His13], nearly identical to what was observed for Cu2+.
In contrast to the strongly binding metals discussed so far, the
metals that bound more weakly to the peptide did so in the C-
terminal region. Na+ was found to bind in the [Val36–Val39]
region using IRMPD, the [Gly37–Gly38] region using CID, and
at Val36 with ECD (see Table 1 and Figure 3). Similarly, K+
appeared to bind in the [Val39–Val40] region using a combina-
tion of the three dissociation methods (see Table 1 and
Supporting Information S4). While it might be expected that
these ions would bind at either a basic or a negatively charged
(deprotonated) site, no polar side chains are found in the region
between Val36 and Val40. As such, these ions were most likely
coordinated purely by backbone amide oxygens, as has been
observed previously in other peptides [74, 75]. The selectivity
for this particular region was most likely due to the very high
backbone flexibility and side chain hydrophobicity of this part of
the peptide. The discrepancy between CID and ECD results for
Na+ is likely due to minor variability in binding site, with
multiple residues being involved as seen for Ni2+. Interestingly,
three N-terminal ECD fragments (c9
+, c10
+, c11
+) were observed
which were bound to Na+. With or without addition of Na+, no
“zIc”-type internal fragments (i.e., possessing a z-type N-
terminus and a c-type C-terminus [76]) or obvious neutral losses
would give rise to signals close enough to those of these c
fragments to be misidentified. Therefore, we conclude that
some—presumably very weak—interaction did in fact occur
between Na+ and certain N-terminal residues, either to complete
the coordination sphere around themetal center or as aminor, co-
existing binding site. Evidently, native top-down ECD was sen-
sitive enough to detect this minor interaction. The K+-bound
analogs of these N-terminal fragments were not observed in
ECD of [M + 3H + K]4+. It is also noteworthy that cleavage
coverage was very good for the sodiated and potassiated pep-
tides, similar to previous observations on small peptoids made by
Ren and colleagues [77].
Based on the discussion so far, one might assume that the
charge state of the metal cation determines the binding strength
and site to amyloid β (1-42)—doubly charged Cu2+, Ni2+, and
Co2+ bound easily to the N-terminal histidine residues of the
peptide, while singly charged Na+ and K+ bound weakly to a
site near the C-terminus. Ca2+, Mg2+, and Mn2+, however, also
bound fairly weakly, and did so at a slightly different site
compared with the alkali metals. As backbone cleavage for
the adduct with Ca2+ was fairly limited, the binding region
could not be specified further than [Gly33–Gly37] using a
combination of our three dissociation methods (Figure 4). Sim-
ilarly, the residues bindingMg2+ were located within the region
[Ile32–Gly37], while the Mn2+ adduct showed more extensive
fragmentation and the binding region in this case was narrowed
down to [Gly33–Met35] (see Table 1 and Supporting
Information S4). It has long been established that the Mn2+
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Figure 2. “Native top-down” fragmentation of native [Aβ + 2H
+ Cu]4+, using (a) IRMPD, (b) IR-ECD, and (c) CID. Fragments
with andwithout a boundmetal ion are summarized outside and
inside the dotted lines in panel (d), respectively, and charge
states are indicated using a color code. In the summary of the
CID results in this panel, Cu-bound fragments with isotope
distributions shifted upward by one hydrogen mass (most likely
due to gas-phase reduction of Cu2+ to Cu+) are indicated with
an asterisk. For IR-ECD, fragments formed through hydrogen
abstraction from the c fragment by the corresponding z frag-
ment are indicated in the same way. The “consensus” binding
region that is consistent with all data obtained from the three
fragmentation methods is highlighted in yellow
Lermyte et al.: Metal Binding to Amyloid ß Studied by Native Top-down FTICR
ion has very similar coordination preferences to those of Mg2+,
resulting in complexes with similar geometries [78]. Therefore,
although the Mg2+ and Ca2+ binding regions could not be deter-
mined as specifically as that for Mn2+ in our MS experiments, it
is likely that all three metals shared the same binding site.
Warmlander and colleagues, based on solution NMR, concluded
that Mn2+ binds primarily to the N-terminal histidine side chains
of amyloid β (1-40) [39], although it was noted that Mn2+ does
not compete for N-terminal histidine binding sites with Cu2+.
Conversely, this couldmerely reflect themuch greater stability of
the Cu2+ complex compared with the Mn2+ analog [79]. These
authors also identified a second binding site involving Glu22 and
Asp23. Presumably, completing the coordination sphere around
Mn2+ required involvement of backbone amide groups and we
note that, as with the alkali metals Na+ and K+, the region found
to bind the metal is very hydrophobic and possesses a relatively
flexible structure. Recently, binding of Ca2+ to α-synuclein was
investigated by Kaminski-Schierle and colleagues using NMR,
and binding was also found to involve a relatively hydrophobic,
flexible part of the peptide [80].
For all three fragmentation methods used here, fragmentation
efficiency, cleavage coverage, and fragment charge states for the
amyloid-metal complexes were broadly similar to those observed
for the metal-free peptide (Supporting Information S5), implying
that metal bridge formation did not significantly affect fragmen-
tation. It has been observed previously that reducing the number
of mobile protons generally leads to reduced fragmentation effi-
ciency in CID, particularly for intermediate and large proteins
[81, 82]. For this reason, fragmentation might be expected to be
inhibited in the amyloid-metal complexes studied here. That such
inhibited fragmentation was not observed is potentially due to the
relatively small size of the amyloid β peptide.
IRMPD of the ternary [Aβ-Fe-NTA] complex re-
sulted in limited fragmentation, and indicated bind-
ing of Fe3+ in the [His13–Asp23] region
As noted earlier, analysis of the ternary [Aβ + Fe3+ + NTA3− +
4H]4+ complex proved particularly challenging. IRMPD pro-
vided some insight, as limited activation resulted in loss of
H3NTA and the observation of [Aβ + Fe + H]
4+ at m/z
1142.053. Upon further irradiation, no loss of iron was ob-
served but limited backbone fragmentation occurred (Figure 1).
Based on the excellent consistency between results from CID,
IRMPD, and ECD for the other eight complexes described in
the previous section, it can be assumed that the IRMPD frag-
ments accurately reflect the gas-phase structure of the [amy-
loid-Fe3+] complex. The observation of Fe3+-bound b22 and y35
fragments shows that the binding region is located between
Ser8 and Gly25, a region containing Tyr, Glu, His, and Asp
residues, all potential Fe3+ binding sites. Due to the complete
absence of signal corresponding to iron-free peptide, the ob-
servation ofmetal-free fragments b12
+ and y19
2+ and absence of
fragments spanning the [His13–Asp23] region can be seen as
evidence that the main interaction region with Fe3+ was likely
situated in this stretch of the peptide sequence. As NTA3−
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Figure 3. “Native top-down” fragmentation of native [Aβ + 3H
+ Na]4+, using (a) IRMPD, (b) IR-ECD, and (c) CID. Fragments
with andwithout a boundmetal ion are summarized outside and
inside the dotted lines in panel (d), respectively, and charge
states are indicated using a color code. For IR-ECD, fragments
formed through hydrogen abstraction from the c fragment by
the corresponding z fragment are indicated with an asterisk.
The “consensus” binding region that is consistent with all data
obtained from the three fragmentationmethods is highlighted in
yellow
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coordinates Fe3+ via three acetate moieties, and its loss was
coupled to the loss of three protons from the peptide, it is very
likely that binding of the iron to the peptide was mediated
through several residues in this region. The precise charge sites
of gas-phase amyloid β (1-42) are unknown at this point, and it
is known that protonation can occur at non-basic amino acid
residues such as glutamine in addition to lysine, arginine, and
histidine [83, 84]. Therefore, our data do not allow us at this
point to ascertain whether the Fe3+ “replaced” three protons
and was coordinated by the (formerly) protonated residues, or
if proton loss and coordination of Fe3+ occur at different sites in
a more complex rearrangement. The amount of information on
the interaction of Fe3+ with amyloid β that is available in the
literature is limited, as the poor solubility of the metal ion and
aggregation of the peptide make this system highly challenging
to investigate using solution-phase techniques [85]. More de-
tailed studies of iron binding to amyloid β are therefore under-
way; however, we note that His13, Glu22, and Asp23 have all
been suggested previously to be involved in this interaction
[54, 86, 87], in good agreement with our findings.
Gas-phase metal reduction and radical-directed
dissociation were observed in CID
of the amyloid-[Co(NH3)6] complex
As discussed, binding of Co2+ involved the same N-terminal
histidines as Cu2+ and Ni2+. Interesting behavior was observed
when cobalt was added as [Co(NH3)6]Cl3, a highly stable Co
3+
complex, rather than Co(II)Cl2. This complex bound to amyloid
β as strongly as Ca2+ or Mn2+ (see Supporting Information S2),
and the theoretical isotope distribution of [M +H + Co(NH3)6]
4+
is compared with the observed distribution in Figure 5a. Upon
CID, the NH3 ligands dissociated and cobalt was transferred to
the N-terminus of the amyloid β peptide. Unexpectedly, rather
than [M + H + Co]4+, the observed isotope distribution of the
resulting peptide-cobalt complex matched that of [M + 2H +
Co]4+ (Figure 5b), which indicates that, during ligand dissocia-
tion, Co3+ was reduced to Co2+. This is somewhat similar to
what was observed by O’Hair and colleagues, using three dif-
ferent hexapeptides and [Co(salen)]OAc (where salen = N,N‘-
ethylenebis(salicylideneaminato)) [88]. This process introduced
a radical site in the peptide, leading to a mix of collision-induced
and radical-directed dissociation (RDD; Figure 5c). The latter
was evidenced by the presence of predominantly a-ions in
addition to the b- and y-type fragments typical for CID, with c-
ions occurring N-terminal to serine, in agreement with the RDD
literature [89, 90].
An a-ion, by definition, is exactly one CO unit lower in
mass than the corresponding b-ion. As such, it is also plausible
that a-ions were formed by CO loss from a b-ion. It is unlikely
that the a-ions observed in our experiments were formed this
way, as they did not appear in CID spectra of the metal-free
peptide, nor in CID of adducts with other metals besides
[Co(NH3)6]
3+ and Cu2+. To further rule out secondary frag-
mentation of “normal” b-ions as the source of the observed a
fragments, we repeated the CID experiment using a collision
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Figure 4. “Native top-down” fragmentation of native [Aβ + 2H +
Ca]4+, using (a) IRMPD, (b) IR-ECD, and (c) CID. Fragments with
andwithout a boundmetal ion are summarized outside and inside
the dotted lines in panel (d), respectively, and charge states are
indicated with a color code. For IR-ECD, fragments formed
through hydrogen abstraction from the c fragment by the corre-
sponding z fragment are indicated with an asterisk. The “consen-
sus” binding region that is consistent with all data obtained from
the three fragmentation methods is highlighted in yellow
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energy of 25 V. As shown in Figure 5d, this still resulted in
observation of both a- and c-ions, making the secondary frag-
mentation mechanism even more unlikely. Furthermore, while
formation of a-ions can be explained through an even-electron
mechanism (i.e., loss of CO), the presence of c-ions in the spectra
is difficult to rationalize without invoking a radical-based
mechanism. We therefore conclude that it is far more likely that
these fragments were indeed formed by RDD. While radical-
directed dissociation has so far only received fairly limited atten-
tion from the MS community, it should be noted that inclusion of
the a and c fragments in the analysis significantly increased
cleavage coverage. A great deal of excellent research on RDD
of peptides and intact proteins has been performed by Julian et al.,
who used homolytic ultraviolet photodissociation of C–I bonds
(either in a lariat crown ether [91], or formed through iodination of
specific amino acid side chains [92–96]) to generate radicals.
However, to the best of our knowledge, this is the first time that
a relatively large peptide has been analyzed in an RDD experi-
ment where the radical was generated through collisional activa-
tion of a peptide-metal complex, as well as the first reported use of
Co(NH3)6Cl3 as an RDD reagent.
Conclusions
Complexes of amyloid β (1-42) with nine bioavailable and po-
tentially (patho)physiologically relevant metals have been studied
with native FTICRmass spectrometry, with the aim of preserving
the metal-peptide interaction. For each metal, the gas-phase bind-
ing region was successfully determined using tandem MS via
three different activation techniques. Consistently, and owing to
the low dielectric permittivity of vacuum, the metal-peptide inter-
actions were sufficiently strong in the gas phase that determina-
tion of the binding region was possible using collision-induced
dissociation, leading to resultsmatching those frommore “gentle”
ECD and IRMPD. This indicates that ligand migration in the gas
phase was not a major issue in tandem MS of peptide-metal
complexes using any of these dissociation techniques, and that
the method that is most conveniently available and/or leads to the
most efficient dissociation can be used by itself to confidently
identify gas-phase binding regions. Formation of an [amyloid-
Fe3+] complex at physiological pH was observed only when a
chelating agent was used to minimize aggregation and precipita-
tion of hydroxide/oxido Fe3+ species, followed bymild gas-phase
activation. This observation is important and has implications for
the design of future studies of peptide interactions with metal ions
which readily form hydroxide and oxido species at physiological
pH, e.g., Al3+ and Zn2+.More extensive activation of the Fe3+
complex suggested interactionwith amyloid β (1-42) in the region
between residues His13 and Asp23.
The binding regions identified in the gas phase using tan-
dem MS are consistent with previous studies using solution-
phase methods. The metals that exhibited the strongest binding
to the peptide all share a very similar binding region involving
the N-terminal histidine residues. The metals studied display a
strong preference for a particular region, although not the same
region. This was observed even for the alkali metals Na+ and
K+, which are often assumed to engage in non-specific binding
in (native) mass spectrometry. Collisional activation of the
complex with [Co(NH3)6]
3+ induced unexpected gas-phase
redox chemistry and radical-directed peptide dissociation, and
inclusion of the resulting fragments in the data analysis
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Figure 5. Observed versus calculated isotope distribution (a)
for [Aβ + H + Co(NH3)6]
4+ and (b) for the [Aβ + 2H + Co]4+ ion
observed upon collisional activation of the complex; the bottom
two panels show top-down fragmentation of native [Aβ + H +
Co(NH3)6]
4+, using CID at (c) 30 V, and (d) 25 V. An overview of
all fragments identified in (c) and (d) can be found in Supporting
Information S6
Lermyte et al.: Metal Binding to Amyloid ß Studied by Native Top-down FTICR
significantly increased the observed cleavage coverage. The
insights gained from this fast, robust MS method, into the
interactions between metal cations and amyloid β, are likely
to contribute to improved understanding and treatment of
Alzheimer’s disease.
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